1. Home
  2. RCKT vs IBEX Comparison

RCKT vs IBEX Comparison

Compare RCKT & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • IBEX
  • Stock Information
  • Founded
  • RCKT 1999
  • IBEX 2017
  • Country
  • RCKT United States
  • IBEX United States
  • Employees
  • RCKT N/A
  • IBEX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • IBEX EDP Services
  • Sector
  • RCKT Health Care
  • IBEX Technology
  • Exchange
  • RCKT Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • RCKT 328.6M
  • IBEX 386.9M
  • IPO Year
  • RCKT N/A
  • IBEX 2020
  • Fundamental
  • Price
  • RCKT $3.28
  • IBEX $29.53
  • Analyst Decision
  • RCKT Buy
  • IBEX Hold
  • Analyst Count
  • RCKT 13
  • IBEX 2
  • Target Price
  • RCKT $12.96
  • IBEX $27.00
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • IBEX 83.2K
  • Earning Date
  • RCKT 08-07-2025
  • IBEX 09-11-2025
  • Dividend Yield
  • RCKT N/A
  • IBEX N/A
  • EPS Growth
  • RCKT N/A
  • IBEX 48.53
  • EPS
  • RCKT N/A
  • IBEX 2.25
  • Revenue
  • RCKT N/A
  • IBEX $535,666,000.00
  • Revenue This Year
  • RCKT N/A
  • IBEX $9.12
  • Revenue Next Year
  • RCKT $108.43
  • IBEX $5.80
  • P/E Ratio
  • RCKT N/A
  • IBEX $13.11
  • Revenue Growth
  • RCKT N/A
  • IBEX 5.35
  • 52 Week Low
  • RCKT $2.19
  • IBEX $16.35
  • 52 Week High
  • RCKT $22.01
  • IBEX $32.08
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • IBEX 53.17
  • Support Level
  • RCKT $2.88
  • IBEX $28.99
  • Resistance Level
  • RCKT $3.74
  • IBEX $30.34
  • Average True Range (ATR)
  • RCKT 0.27
  • IBEX 0.75
  • MACD
  • RCKT 0.02
  • IBEX 0.08
  • Stochastic Oscillator
  • RCKT 35.43
  • IBEX 61.06

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: